Prolonged corticosteroid therapy and steroid-sparing maintenance immunotherapy lower relapse risk in pediatric and adult MOGAD. Hoshina Y, Liu S, Wright MA, Delic A, et al. J Neuroimmunol 2025;407:578709.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Hoshina Y, Liu S, Wright MA, Delic A, et al. Prolonged corticosteroid therapy and steroid-sparing maintenance immunotherapy lower relapse risk in pediatric and adult MOGAD. J Neuroimmunol 2025;407:578709.
PMID: 40763382